PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WARREN, N.J., Dec. 23, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.
新澤西州禾倫，2024年12月23日 /PRNewswire/ — PTC Therapeutics, Inc.（納斯達克股票代碼：PTCT）今天宣佈，首席執行官馬修·克萊因萬德將於太平洋時間2025年1月13日星期一上午11點15分/美國東部時間下午2點15分出席第43屆摩根大通醫療年度會議。
The presentation will be webcast live on the Events and Presentations page under the Investors section of PTC Therapeutics' website at and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
該演示將在PTC Therapeutics網站 「投資者」 部分下的 「活動和演示」 頁面上進行網絡直播 並將在演示結束後存檔 30 天。建議用戶在網絡直播開始前幾分鐘連接到 PTC 的網站，以確保及時連接。
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at and follow us on Facebook, Instagram, LinkedIn and X.
關於 PTC Therapeutics, Inc.
PTC是一家全球生物製藥公司，致力於發現、開發和商業化臨牀差異化藥物，爲患有罕見疾病的兒童和成人提供益處。PTC的創新能力以識別新療法和在全球範圍內實現產品商業化的能力是推動對強大而多元化的變革性藥物管道進行投資的基礎。要了解有關 PTC 的更多信息，請訪問我們並在臉書、Instagram、LinkedIn 和 X 上關注我們。
For More Information:
欲了解更多信息：
Investors:
Ellen Cavaleri
+1 (615) 618-6228
[email protected]
投資者：
艾倫·卡瓦萊裏
+1 (615) 618-6228
[電子郵件保護]
Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]
媒體：
珍妮·克萊門特
+1 (908) 912-9406
[電子郵件保護]
SOURCE PTC Therapeutics, Inc.
來源 PTC Therapeutics, Inc.